What Conditions or Symptoms Can Be Treated with a Spinal Cord Stimulator?
1. Background and How It Works
Spinal Cord Stimulation (SCS) is a form of neuromodulation used to manage selected types of chronic pain. The concept was historically influenced by the Gate Control Theory of pain proposed by Melzack & Wall in 1965. An SCS system delivers programmed electrical signals through electrodes positioned in the epidural space near the spinal cord. These signals modify pain processing within the nervous system and may reduce the perception of pain. Modern SCS mechanisms are more complex than the original Gate Control Theory and may involve several spinal and supraspinal pathways. SCS does not repair damaged nerves or correct the structural cause of every pain condition and is generally considered for carefully selected patients whose chronic pain has not been adequately controlled with appropriate conventional treatment.
2. Conditions and Symptoms for Which SCS May Be Considered
Based on clinical evidence, current indications, and specialist assessment, SCS may be considered for selected patients with conditions such as:
Persistent Spinal Pain Syndrome after spine surgery, historically referred to as Failed Back Surgery Syndrome (FBSS), particularly when persistent neuropathic back or leg pain remains after surgery and further corrective surgery is not expected to provide sufficient benefit.
Chronic neuropathic back and/or leg pain in selected patients who have not achieved adequate relief from appropriate conservative treatment. Different SCS waveforms, including high-frequency stimulation, may be considered depending on the clinical condition and device.
Complex Regional Pain Syndrome (CRPS), particularly in selected patients with persistent pain despite appropriate multidisciplinary treatment.
Selected neuropathic pain conditions, including painful diabetic neuropathy for which certain SCS systems have supporting clinical evidence. SCS may also be considered in selected refractory neuropathic or ischemic pain conditions under specialist evaluation. Evidence and regulatory indications vary considerably among conditions, so SCS should not be considered a standard treatment for every type of peripheral neuropathy, phantom limb pain, post-herpetic neuralgia, ischemic limb pain, abdominal pain, or chest pain.
SCS is also being studied experimentally for neurological and motor disorders. Research involving spinal cord stimulation in conditions such as spinal cord injury or Parkinson’s disease should be distinguished from established SCS treatment for chronic pain. It is not currently a routine treatment for Parkinson’s disease or spinal muscular atrophy (SMA).
3. Clinical Evidence
Randomized and prospective clinical studies have shown that appropriately selected patients with persistent neuropathic pain after spine surgery may obtain meaningful pain relief and functional improvement from SCS compared with some conventional treatment strategies.
Clinical trials have also demonstrated benefits of SCS for selected patients with persistent spinal pain and other specific neuropathic pain conditions. The proportion of patients who respond varies among studies, devices, pain diagnoses, follow-up periods, and definitions of treatment success.
Studies of high-frequency SCS, including 10-kHz stimulation, have reported clinically meaningful improvements in back and leg pain in selected patients. However, treatment response is individual and pain relief is not guaranteed to persist indefinitely.
Comparisons such as a single universal Number Needed to Treat (NNT) for SCS versus all medications should be interpreted cautiously because the treatments, patient populations, outcomes, and study designs are not directly interchangeable.
4. Evaluation and Implantation Process
4.1 Patient Selection and Trial Phase
Before SCS is considered, patients generally undergo a comprehensive assessment that may include medical and neurological examination, review of previous treatments and imaging when clinically indicated, and assessment of psychological and psychosocial factors that may influence treatment outcomes.
During the trial phase, temporary percutaneous leads are usually positioned in the epidural space under image guidance and connected to an external pulse generator.
The trial commonly lasts several days, although the exact duration varies. Meaningful improvement in pain, function, sleep, medication requirements, or personally relevant treatment goals is assessed before deciding whether permanent implantation is appropriate. A pain reduction of approximately 50% has traditionally been used as one measure of a successful trial, but the decision should not rely on a single percentage alone.
4.2 Permanent Implantation
If the trial provides meaningful benefit and the patient remains an appropriate candidate, permanent leads and an implantable pulse generator (IPG) may be implanted. The generator is usually placed under the skin in an area such as the buttock, flank, or abdomen, depending on the patient’s anatomy and device.
The leads are generally positioned using image guidance, commonly fluoroscopy. The implantation technique, anesthesia, and type of lead vary according to the system and patient.
After implantation, the SCS system can be programmed and adjusted to optimize therapy. Available stimulation patterns and programming options depend on the specific device.
5. Potential Benefits and Important Considerations
Potential benefits: In patients who respond to treatment, SCS may reduce chronic pain, improve function and quality of life, and in some cases reduce reliance on pain medication, including opioids. These benefits vary and are not guaranteed.
Limitations: Not every patient responds adequately, and treatment effectiveness may change over time. Some patients may eventually require revision or removal of the device.
Possible complications: These include pain at the implant site, bleeding, infection, lead migration or breakage, hardware malfunction, unwanted stimulation, loss of treatment effectiveness, dural puncture and headache, and rarely neurological injury. Revision or removal may be required in some cases.
Precautions: MRI compatibility depends on the specific SCS system and the manufacturer’s conditions. Some modern systems are MRI-conditional rather than universally MRI-compatible. Patients should follow postoperative activity restrictions and device instructions provided by their clinical team. Bleeding risk, infection risk, medications, psychological and psychosocial factors, and other medical conditions should be assessed before implantation.
6. Treatment Approach at Sapiens Hospital
At Sapiens Hospital, chronic pain management may use a comprehensive biopsychosocial approach that considers the patient’s diagnosis, physical function, psychological and social factors, previous treatment, and individual goals.
Non-surgical interventions may include medication, image-guided procedures, selected interventional pain treatments such as RFA, and individualized physical rehabilitation. Treatments such as PRP or Botox have specific indications and are not routine treatments for every chronic pain condition.
Neuromodulation and SCS:
Patients are evaluated by physicians experienced in pain management and neuromodulation.
A temporary SCS trial may be performed and evaluated according to improvement in pain, function, and individualized treatment goals.
Permanent implantation may be considered when the trial provides meaningful benefit and the patient is an appropriate candidate.
After implantation, follow-up includes wound and device assessment, programming adjustments, monitoring of treatment response, and management of potential complications.
Integration with other treatments: SCS is generally part of an overall pain-management plan and may be combined with appropriate medication, physical rehabilitation, psychological support, and ongoing follow-up.
Summary
Spinal Cord Stimulation is an important neuromodulation option for carefully selected patients with certain chronic neuropathic pain conditions, particularly when appropriate conventional treatments have not provided sufficient benefit. It is not a treatment for every type of chronic pain, and it does not repair the underlying structural problem in all conditions. Appropriate patient selection, a trial phase when indicated, individualized implantation and programming, and systematic long-term follow-up are important parts of SCS treatment. Sapiens Hospital emphasizes comprehensive evaluation to determine whether SCS or another treatment approach is most appropriate for each patient.
References
Melzack R, Wall PD. Pain mechanisms: a new theory. Science. 1965.
Kumar K, et al. Spinal cord stimulation versus conventional medical management for neuropathic pain in patients with failed back surgery syndrome. Pain. 2007.
North RB, et al. Spinal cord stimulation versus repeated lumbosacral spine surgery for chronic pain: a randomized, controlled trial. Neurosurgery. 2005.
Kapural L, et al. Novel 10-kHz high-frequency therapy (HF10 Therapy) is superior to traditional low-frequency spinal cord stimulation for the treatment of chronic back and leg pain. Anesthesiology. 2015.
Petersen EA, et al. Effect of high-frequency (10-kHz) spinal cord stimulation in patients with painful diabetic neuropathy. JAMA Neurology. 2021.